Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Roche
Roche
China's Jemincare nabs $650M biobucks pact with Roche's Genentech for prostate cancer hopeful
Fierce Biotech
Thu, 08/18/22 - 12:36 pm
Roche
Genentech
China
Jemincare
biobucks
prostate cancer
Roche’s Polivy continues its regulatory dance, will head to FDA for a form of blood cancer
Endpoints
Tue, 08/16/22 - 11:17 am
Roche
Polivy
diffuse large B-cell lymphoma
FDA
Roche, Genentech sign license deal with Kiniksa for vixarelimab
Pharmaceutical Business Review
Thu, 08/4/22 - 10:54 am
Kiniksa Pharmaceuticals
Roche
Genentech
vixarelimab
monoclonal antibodies
Coherus wins FDA approval for second Lucentis biosimilar, its third drug
BioPharma Dive
Wed, 08/3/22 - 09:26 pm
Coherus Biosciences
biosimilars
Lucentis
Roche
Cimerli
It’s official: Roche is a Car-T player
EP Vantage
Wed, 08/3/22 - 10:42 am
Roche
CAR-T
oncology
Poseida Therapeutics
Racing Merck and Pfizer, Roche readies to file subcutaneous Tecentriq after posting phase 3 data
Fierce Pharma
Tue, 08/2/22 - 10:54 am
Roche
Pfizer
Merck
Tecentriq
clinical trials
cancer
checkpoint inhibitors
Sarepta shares buoyed by pledge to seek an early swift review for Duchenne gene therapy
Fierce Biotech
Fri, 07/29/22 - 10:20 am
Sarepta Therapeutics
SRP-9001
Duchenne Muscular Dystrophy
Roche
accelerated approvals
Look out, Regeneron. As the threat from Roche's Vabysmo grows, one team of analysts slashes its Eylea sales estimate
Fierce Pharma
Mon, 07/25/22 - 10:00 pm
Regeneron
Eylea
Roche
Vabysmo
Roche, Biogen temper Alzheimer’s expectations in Q2 calls. Will Lilly follow suit in August?
Fierce Biotech
Fri, 07/22/22 - 11:21 am
Alzheimer's disease
Roche
Biogen
Eli Lilly
lecanemab
gantenerumab
Aduhelm
Roche Sees More Growth Opportunities for Phesgo, Tecentriq; Still Optimistic on Tiragolumab
Precision Oncology News
Fri, 07/22/22 - 10:14 am
Roche
earnings
oncology
Phesgo
Tecentriq
Roche CEO Severin Schwan to step down after 14 years
Pharmaforum
Thu, 07/21/22 - 10:42 am
Roche
Pharma CEOs
Severin Schwan
Thomas Schinecker
Genentech rides up to 2nd target in Bicycle immuno-oncology collab
Fierce Biotech
Tue, 07/12/22 - 10:52 am
Genentech
Bicycle Therapeutics
Roche
immuno-oncology
Ionis hands off an antisense drug for kidney disease, giving all rights to Roche
Endpoints
Mon, 07/11/22 - 06:23 pm
Ionis Pharmaceuticals
Roche
IONIS-FB-LRx
clinical trials
immunoglobin A nephropathy
kidney disease
AstraZeneca, GSK and more weathered Q2's economic headwinds, but Roche's stock took a hit: analysts
Fierce Pharma
Wed, 07/6/22 - 11:41 pm
AstraZeneca
GSK
Roche
FDA to decide on Roche’s lymphoma drug Lunsumio before year-end
Pharmaforum
Wed, 07/6/22 - 10:49 am
Roche
Lunsumio
follicular lymphoma
T-cell engager
FDA
priority review
Medtech research spending set to slow in 2022
EP Vantage
Tue, 07/5/22 - 10:57 am
Medtech
R&D
Abbott Labs
Becton Dickinson
Boston Scientific
EssilorLuxottica
JNJ
Medtronic
Philips
Roche
Siemens Healthineers
Stryker
Roche, Pfizer top list of ESG leaders in patient groups' view, but many still think pharmas can do better
Endpoints
Thu, 06/30/22 - 10:17 pm
ESG
Roche
Pfizer
patient advocacy groups
Fierce NextGen: Despite another key trial failure, Alzheimer's therapy developers find reason for optimism
Fierce Biotech
Wed, 06/29/22 - 10:59 am
Alzheimer's disease
clinical trials
crenezumab
Roche
Genentech
Big pharma’s key third-quarter data
EP Vantage
Tue, 06/28/22 - 10:37 am
GSK
Roche
Pfizer
JNJ
AstraZeneca
Novo Nordisk vaccines
clinical trials
pneumococcal disease
crovalimab
rheumatoid arthritis
Up-and-down test sales and a bigger Medtronic: medtech in 2028
EP Vantage
Mon, 06/20/22 - 10:35 am
Medtech
devices
Medtronic
Siemens
Stryker
Roche
Pages
« first
‹ previous
…
8
9
10
11
12
13
14
15
16
…
next ›
last »